ANAB PB Ratio
136.13×TTM
Retrieved:
ANAB FY P/B Ratio
97.27×-9.67×
2013-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ANAB pb ratio history
Price-to-book ratio. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.
| Period ending | PB Ratio |
|---|---|
| 24.1371× | |
| 3.5363× | |
| 4.3639× | |
| 2.2201× | |
| 1.7832× | |
| 0.9862× | |
| 0.7236× | |
| 2.1575× | |
| 4.3187× | |
| 0.7609× | |
| 0.6827× | |
| 4.6904× | |
| 86.9229× |
Compare pb ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) pb ratio
- Bridgebio Pharma Inc (BBIO) pb ratio
- Brightspring Health Services Inc (BTSG) pb ratio
- Madrigal Pharmaceuticals Inc (MDGL) pb ratio
- Ensign Group Inc (ENSG) pb ratio
- Glaukos Corp (GKOS) pb ratio
- Vaxcyte Inc (PCVX) pb ratio
- Krystal Biotech Inc (KRYS) pb ratio
Compare all covered stocks by pb ratio →
All ANAB financial metrics · ANAB stock overview · How to interpret financial metrics
